Flavopiridol-Resistant MCF-7 Cell Line (FLV500)
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Mammary |
| Organism |
Human (H. sapiens) |
| Donor History |
Female ,Caucasian ,69 ,Adenocarcinoma |
| Growth Properties |
Adherent ,Cuboidal |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. RPMI 1640 Medium (TM503) + 10% FBS + 2 mM L-Glutamine (G275) + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. |
| Immortalization Method |
Tumor Cell Line |
| Full Information |
https://www.abmgood.com/flavopiridol-resistant-mcf-7-cell-line-flv500.html |
These cell lines were developed using MCF-7, a human breast cancer cell line expressing estrogren, progesterone and glucocorticoid receptors. Flavopiridol is a cdk inhibitor used in human clinial trials, however, the cellular resistance mechanisms are not yet understood. This MCF-7 sub-cell line (FLV500) is resistant to 500 nM flavopiridol. Cells were selected during MF-7 cell exposure to increasing flavopiridol concentrations. The cell lines are suitable for drug discovery related research.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
